openPR Logo
Press release

Lymphedema Treatment Market to Hit US$ 2.3 Billion by 2031, Driven by Technological Advancements

05-10-2025 02:55 PM CET | Health & Medicine

Press release from: DataM Intelligence 4market Research LLP

Lymphedema Treatment Market

Lymphedema Treatment Market

Lymphedema Treatment Market report, published by DataM Intelligence, delivers detailed insights and analysis on major market trends, growth prospects, and emerging challenges. With a strong focus on providing actionable intelligence, DataM Intelligence enables businesses to make well-informed decisions and maintain a competitive edge. By blending both qualitative and quantitative research approaches, the company offers thorough reports that support clients in navigating complex market environments, driving strategic expansion, and capitalizing on new opportunities in today's rapidly evolving global landscape.

Lymphedema Treatment Market reached US$ 1.1 billion in 2023 and is expected to reach US$ 2.3 billion by 2031 growing with a CAGR of 9.5% during the forecast period 2024-2031.

Request a Free Sample PDF of This Report (Corporate Email IDs Receive Priority Service): https://datamintelligence.com/download-sample/lymphedema-treatment-market?rk

Advancing Technologies Accelerate Growth in the Lymphedema Treatment Market

Technological innovation in the healthcare sector is a key factor propelling the growth of the global lymphedema treatment market. Lymphedema, a chronic condition caused by impaired lymphatic drainage, is increasingly being addressed through advanced medical technologies and solutions.

Leading companies are introducing innovative platforms and devices that translate research breakthroughs into effective treatments, significantly improving patient care. For example, in October 2022, ImpediMed Limited expanded the use of its SOZO Digital Health Platform across top cancer centers to reduce the burden of lymphedema in breast cancer patients.

Additionally, continuous R&D efforts and product launches by key players are driving momentum in the market. In April 2023, AIROS Medical, Inc. received FDA clearance for its new peristaltic pneumatic compression device and truncal garments for lymphedema therapy. Similarly, in April 2022, Koya Medical launched the Dayspring active compression system-FDA-cleared as the first non-pneumatic dynamic compression therapy-for treating lymphedema and venous disorders in the lower limbs.

Lymphedema Treatment Market Recent Development:

✔ In August 2023, Calamos Advisors LLC made a notable investment in Tactile Systems Technology, Inc., acquiring 60,861 shares of the company's stock for approximately $999,000. This purchase represented a 0.26% ownership stake in Tactile Systems Technology, a medical technology company focused on developing innovative devices for treating conditions such as lymphedema, venous disorders, and pulmonary secretions retention.

List of the Key Players in the Lymphedema Treatment Market:

Kite Pharma, Johnson, and Johnson, Sanofi S.A, LGM Pharma, Hubei Xunda Pharma, Sigma Aldrich, Midas Pharma, Oishi Koseido Co. Ltd, Glentham Life Sciences, Taro Pharmaceuticals.

Assessing the Effects of U.S. Tariffs on the Lymphedema Treatment Market

The U.S. tariff war is reshaping how businesses analyze trends and make strategic decisions. As tariffs drive up costs and disrupt supply chains, companies are increasingly focused on understanding consumer behavior, identifying new sourcing opportunities, and adjusting their operations to remain competitive. The ongoing uncertainty has created a stronger demand for timely insights and data-driven strategies to navigate shifting trade dynamics and economic pressures.

Research Process:

Both primary and secondary data sources have been used in the global Lymphedema Treatment Market research report. During the research process, a wide range of industry-affecting factors are examined, including governmental regulations, market conditions, competitive levels, historical data, market situation, technological advancements, upcoming developments, in related businesses, as well as market volatility, prospects, potential barriers, and challenges.

Make an Enquiry for purchasing this Report @ https://www.datamintelligence.com/enquiry/lymphedema-treatment-market?rk

Segment Covered in the Lymphedema Treatment Market:

✦ By Type: Primary Lymphedema, Secondary Lymphedema.

✦ By Treatment: Stem Cell Therapy, Decongestive therapy, Surgery, Drug Therapy, Laser Therapy, Others.

✦ By End Users: Hospital, Retail Pharmacy, Online Pharmacy, Others.

Regional Analysis for Lymphedema Treatment Market:

⇥ North America (U.S., Canada, Mexico)

⇥ Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)

⇥ Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)

⇥ South America (Colombia, Brazil, Argentina, Rest of South America)

⇥ Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)

People Also Ask:

Most Frequently Asked Questions in the Lymphedema Treatment Market Research Industry:

➠ What are the global figures for sales, production, consumption, imports, and exports in the Lymphedema Treatment market?

➠ Who are the top manufacturers in the global Lymphedema Treatment industry, and what is their current status in terms of production capacity, output, sales performance, pricing structure, cost analysis, profit margins, and overall revenue?

➠ What key opportunities are available for vendors in the Lymphedema Treatment market, and what challenges are they likely to encounter?

➠ Which application areas, end-user segments, or product types are projected to experience significant growth, and how is the market share distributed among them?

➠ What are the major drivers and barriers influencing the growth trajectory of the Lymphedema Treatment market?

➠ What are the primary sales, marketing, and distribution strategies used across the global Lymphedema Treatment industry landscape?

Browse More Reports: https://www.datamintelligence.com/research-report/lymphedema-treatment-market?rk

Contact Us -

Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -

DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.

Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Lymphedema Treatment Market to Hit US$ 2.3 Billion by 2031, Driven by Technological Advancements here

News-ID: 4009035 • Views:

More Releases from DataM Intelligence 4market Research LLP

Japan CAR-T Cell Therapy Market Forecast 2025-2033: Advancements in Allogeneic Therapies and Combination Treatments | Key Japanese Pharmaceutical Players Invest in Next-Gen CAR-T Cell Technologies
Japan CAR-T Cell Therapy Market Forecast 2025-2033: Advancements in Allogeneic T …
The Japan CAR-T cell therapies market reached US$ 346.00 million in 2024 and is expected to reach US$ 1,350.15 million by 2033, growing at a CAGR of 16.3% during the forecast period 2025-2033. The CAR-T Cell Therapies Market in Japan involves genetically engineered T-cells targeting cancer-specific antigens. Growth is driven by rising cancer incidence, advanced immunotherapies, and government support. Hospitals and specialized oncology centers are key end-users. Clinical trials focus on
Advanced Rocket and Missile Propulsion Systems Market to Reach USD 77.58 Billion by 2032 | Driving Innovations in Hypersonics and Green Propellants
Advanced Rocket and Missile Propulsion Systems Market to Reach USD 77.58 Billion …
Global Advanced Rocket and Missile Propulsion Systems Market size reached US$ 38.79 billion in 2024 and is expected to reach US$ 77.58 billion by 2032, growing with a CAGR of 9.05% during the forecast period 2025-2032. Advanced Rocket and Missile Propulsion Systems include solid, liquid, and hybrid engines used in defense, space, and aerospace applications. Growth is driven by defense modernization, space exploration, and missile defense initiatives. Technologies focus on high
Transparent Food Labeling Market to Reach USD 79.21 Billion by 2032, Growing at a CAGR of 7.87% | Increasing Demand for Organic, Non-GMO, and Allergen-Free Labels
Transparent Food Labeling Market to Reach USD 79.21 Billion by 2032, Growing at …
Global transparent food labeling market size reached US$ 43.21 billion in 2024 and is expected to reach US$ 79.21 billion by 2032, growing with a CAGR of 7.87% during the forecast period 2025-2032. Transparent Food Labeling involves providing clear, accurate information about ingredients, nutritional content, and allergens on packaged foods. Growth is driven by rising consumer awareness, health consciousness, and regulatory requirements. Labels often highlight organic, non-GMO, or allergen-free claims.
Regulatory Technology Market Outlook 2025-2032: Expansion in Cloud-Based and AI-Powered Compliance Tools | AI-Driven Analytics and Blockchain Enhance Efficiency in RegTech Compliance and Reporting
Regulatory Technology Market Outlook 2025-2032: Expansion in Cloud-Based and AI- …
Global RegTech Market reached US$ 20.04 billion in 2024 and is expected to reach US$ 33.36 billion by 2032, growing with a CAGR of 6.75% during the forecast period 2025-2032. The Regulatory Technology (RegTech) Market provides software and tools to ensure compliance, risk management, and reporting for financial institutions. Growth is driven by increasing regulations, fintech adoption, and fraud prevention needs. Solutions include AI-driven analytics, blockchain, and automated reporting systems.

All 5 Releases


More Releases for Lymphedema

Lymphedema Market to Reach USD 7.4 Billion by 2034
Lymphedema is a chronic, progressive condition characterized by the accumulation of lymphatic fluid in the body's tissues, leading to swelling, discomfort, and recurrent infections. It can be primary (genetic) or secondary (caused by cancer treatments, infections, or trauma). With rising cases of cancer survivorship, increasing awareness of lymphatic health, and advancements in compression devices, microsurgical techniques, and digital health solutions, the Lymphedema Market is entering a transformative growth phase. Download Full
Lymphedema Treatment Market Growth and Analysis by 2028
The lymphedema treatment market is projected to reach US$ 11.58 billion by 2028 from US$ 8.15 billion in 2021; it is expected to grow at a CAGR of 5.1% from 2021 to 2028. Lymphedema is a condition in which the body enlarges abnormally due to the lymphostasis caused by lymphatic system dysfunction. It most commonly affects the lower extremity (90%), upper extremity (10%), and genitalia (1%). Primary lymphedema is present at
Lymphedema Diagnostics Market Analysis Research Report [2024-2030]
The Lymphedema Diagnostics Market request is passing substantial growth, driven by the adding relinquishment of digital reclamation results across diligence. Organizations, especially in sectors with high development or large- scale hiring requirements, are decreasingly integrating to streamline and ameliorate hiring effectiveness. crucial factors boosting demand include a lesser focus on enhancing the seeker experience, managing large aspirant pools effectively, and using data analytics to optimize reclamation strategies. also, the
Canada's Hidden Health Crisis: Over 1.25 Million Living with Lymphedema
Imagine living with incurable swelling that impairs your ability to move, work, or enjoy life-and having no access to treatment. For up to 1.25 million Canadians this is their daily reality. Lymphedema, a chronic and debilitating condition causing permanent swelling, affects 1 in 33 Canadians, yet it remains widely undiagnosed and untreated due to systemic healthcare barriers. The Canadian Lymphedema Framework (CLF) has released this staggering new prevalence data in
Lymphedema Diagnostics Market Soars as Awareness of Lymphedema Detection Grows - …
The Lymphedema Diagnostics Market is witnessing a steady growth trajectory, driven by technological advancements and rising awareness about lymphedema, a chronic condition characterized by swelling due to lymphatic fluid accumulation. With a market valuation of US$ 41.9 million in 2023, this sector is projected to grow at a CAGR of 4.8%, reaching US$ 70.7 million by 2034. A combination of factors, including advancements in diagnostic imaging, the increasing prevalence of
Lymphedema Treatment Market Is Likely to Enjoy a Tremendous Growth
"Leading market research firm SkyQuest Technology Group recently released a study titled ' Lymphedema Treatment Market Global Size, Share, Growth, Industry Trends, Opportunity and Forecast 2024-2031,' This study Lymphedema Treatment report offers a thorough analysis of the market, as well as competitor and geographical analysis and a focus on the most recent technological developments. The research study on the Lymphedema Treatment Market extensively demonstrates existing and upcoming opportunities, profitability, revenue